$LQDA
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Healthcare
Sector
Biotechnology
Industry
Roger A. Jeffs
CEO
170
Employees
$57.59
Current Price
$3.40B
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 8 | $18,405,167.50 | 368,893 | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 2 | 12 | $22,533,032.50 | 468,893 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 4 | 16 | $24,393,984.69 | 514,996 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 9 | 41 | $46,572,724.60 | 1,080,397 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 10 | 51 | $52,157,974.48 | 1,236,498 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| May 11, 2026 | Bloch Stephen M Director | Sale | 115,479 | $49.45 | $5,709,882.25 | View Details |
| May 11, 2026 | Bloch Stephen M Director | Sale | 14,207 | $53.25 | $756,565.37 | View Details |
| May 11, 2026 | Bloch Stephen M Director | Sale | 75,293 | $52.38 | $3,943,538.64 | View Details |
| May 11, 2026 | Bloch Stephen M Director | Sale | 10,500 | $51.31 | $538,762.35 | View Details |
| May 11, 2026 | Bloch Stephen M Director | Sale | 27,613 | $50.10 | $1,383,491.38 | View Details |
| May 11, 2026 | Bloch Stephen M Director | Sale | 75,801 | $48.61 | $3,684,535.01 | View Details |
| May 12, 2026 | JEFFS ROGER Director | Sale | 25,000 | $54.04 | $1,350,990.00 | View Details |
| May 8, 2026 | JEFFS ROGER Director | Sale | 25,000 | $42.14 | $1,053,565.00 | View Details |
| May 11, 2026 | JEFFS ROGER Director | Sale | 25,000 | $41.50 | $1,037,402.50 | View Details |
| May 5, 2026 | JEFFS ROGER Director | Sale | 25,000 | $40.10 | $1,002,592.50 | View Details |
| May 6, 2026 | JEFFS ROGER Director | Sale | 25,000 | $40.78 | $1,019,572.50 | View Details |
| May 7, 2026 | JEFFS ROGER Director | Sale | 25,000 | $42.09 | $1,052,135.00 | View Details |
| Apr 27, 2026 | Boyle Dana Chief Accounting Officer | Sale | 1,576 | $37.78 | $59,541.28 | View Details |
| Apr 27, 2026 | Adair Jason Chief Business Officer | Sale | 688 | $41.65 | $28,655.20 | View Details |
| Apr 17, 2026 | JEFFS ROGER Director | Sale | 18,839 | $40.60 | $764,955.71 | View Details |
| Apr 14, 2026 | JEFFS ROGER Director | Sale | 3,300 | $40.00 | $132,000.00 | View Details |
| Apr 15, 2026 | JEFFS ROGER Director | Sale | 25,000 | $40.14 | $1,003,522.50 | View Details |
| Apr 16, 2026 | JEFFS ROGER Director | Sale | 25,000 | $40.31 | $1,007,800.00 | View Details |
| Apr 15, 2026 | Kaseta Michael CFO and COO | Sale | 86,971 | $40.14 | $3,491,094.21 | View Details |
| Apr 14, 2026 | Kaseta Michael CFO and COO | Sale | 3,000 | $40.00 | $120,000.00 | View Details |
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
Estimated$0.01
ActualN/A
Revenue
EstimatedN/A
ActualN/A